Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance.
- NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_assertion description "[Using immunohistochemistry, a score including PAK1 and co-expression of PKA and ER?S305-P (PKA/ER?S305-P) was developed on a training set consisting of 103 patients treated with tamoxifen for metastatic disease, and validated on 231 patients randomized between adjuvant tamoxifen or no treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance.
- NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_assertion evidence source_evidence_literature NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance.
- NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_assertion SIO_000772 20213082 NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance.
- NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_assertion wasDerivedFrom befree-20140225 NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance.
- NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_assertion wasGeneratedBy ECO_0000203 NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP841033.RAiFRvlFKNIaTFO6Q2kdZIuUPx_GrUUdjf4mRQ-gurHmk130_provenance.